CRISPR Therapeutics just dropped some insane early results: their new gene-editing CAR T therapy, zugo-cel, is showing a 90% response rate in aggressive blood cancer patients. Even crazier? 70% had a complete response! Side effects are looking manageable so far, and they’re also testing it for autoimmune diseases. This could be a game-changer for cancer treatment—watch this space for more updates in 2026! #Health #BodyHealth #CRISPR